U.S. Pharmaceutical Sales - Q2 2012

The following is a list of the top 100 prescribed medicines by U.S. National Sales in Q2 2012. Figures include sales through both retail and hospital channels, listed by drug name and sales value in U.S. dollars.

Last updated: February 2014 (updated quarterly).

Top 100 Drugs for Q2 2012 by Sales

Rank Drug Sales ($000)
1 (1) Nexium
AstraZeneca Pharmaceuticals, LP
-1.12% Stats
2 (1) Abilify
Otsuka Pharmaceutical Co., Ltd
2.91% Stats
3 (1) Singulair
Merck & Co., Inc.
4.01% Stats
4 (2) Advair Diskus
GlaxoSmithKline
-1.25% Stats
5 (2) Crestor
AstraZeneca Pharmaceuticals, LP
0.61% Stats
6 (2) Cymbalta
Eli Lilly and Company
2.77% Stats
7 (3) Humira
AbbVie, Inc.
9.43% Stats
8 (4) Enbrel
Amgen Inc.
6.51% Stats
9 (8) Plavix
Bristol-Myers Squibb Company
-42.33% Stats
10 (1) Remicade
Centocor Ortho Biotech, Inc
3.76% Stats
11 (2) Neulasta
Amgen Inc.
-0.86% Stats
12 (3) Rituxan
Genentech, Inc (member of Roche group)
8.26% Stats
13 (3) Copaxone
Teva Pharmaceuticals
6.65% Stats
14 (5) atorvastatin
Generic
-17.68% Stats
15 (3) OxyContin
3.14% Stats
16 (1) Atripla
Gilead Sciences, Inc.
-1.70% Stats
17 (2) Spiriva
Boehringer Ingelheim Pharmaceuticals, Inc
0.21% Stats
18 (2) Avastin
Genentech, Inc (member of Roche group)
2.46% Stats
19 (3) Januvia
Merck & Co., Inc.
3.81% Stats
20 (6) Lipitor
Pfizer Inc
-31.09% Stats
21 Actos
Takeda Pharmaceuticals U.S.A., Inc
-8.94% Stats
22 (5) Epogen
Amgen Inc.
13.33% Stats
23 Truvada
Gilead Sciences, Inc.
-0.60% Stats
24 Lantus
Sanofi (formerly Sanofi Aventis)
1.81% Stats
25 Diovan
Novartis Corporation
-3.79% Stats
26 (3) Lantus Solostar
Sanofi (formerly Sanofi Aventis)
7.28% Stats
27 (3) enoxaparin
Generic
4.44% Stats
28 Lyrica
Pfizer Inc
-0.78% Stats
29 (2) Eloxatin
Sanofi (formerly Sanofi Aventis)
5.24% Stats
30 (3) Herceptin
Genentech, Inc (member of Roche group)
6.67% Stats
31 (1) Celebrex
Pfizer Inc
1.43% Stats
32 (46) escitalopram
Generic
98.11% Stats
33 (6) Avonex
Biogen Idec
6.61% Stats
34 (4) Gleevec
Novartis Corporation
5.21% Stats
35 (2) Namenda
Forest Pharmaceuticals, Inc
4.16% Stats
36 (2) Diovan HCT
Novartis Corporation
-3.14% Stats
37 (2) Lucentis
Genentech, Inc (member of Roche group)
-4.92% Stats
38 (2) Vyvanse
Shire US Inc
-3.00% Stats
39 (4) OneTouch
-1.14% Stats
40 (2) Incivek
Vertex Pharmaceuticals
-2.91% Stats
41 (4) methylphenidate
Generic
2.88% Stats
42 (2) Suboxone
Reckitt Benckiser Pharmaceuticals Inc.
1.17% Stats
43 (3) Zetia
Merck & Co., Inc.
2.52% Stats
44 (3) AndroGel
AbbVie, Inc.
4.81% Stats
45 (4) Lidoderm
Endo Pharmaceuticals
1.43% Stats
46 (5) Symbicort
AstraZeneca Pharmaceuticals, LP
1.42% Stats
47 (11) Procrit
Janssen Pharmaceuticals, Inc
10.72% Stats
48 (2) TriCor
Abbott Laboratories
-2.62% Stats
49 (13) Rebif
9.73% Stats
50 (9) Alimta
Eli Lilly and Company
6.53% Stats
51 (4) amphetamine/dextroamphetamine
Generic
-0.10% Stats
52 (4) Nasonex
Merck & Co., Inc.
-0.76% Stats
53 (1) Combivent
Boehringer Ingelheim Pharmaceuticals, Inc
-5.34% Stats
54 (3) Novolog
Novo Nordisk, Inc.
1.41% Stats
55 (1) Seroquel XR
AstraZeneca Pharmaceuticals, LP
-5.08% Stats
56 (4) Viagra
Pfizer Inc
-1.77% Stats
57 (11) Levemir
Novo Nordisk, Inc.
6.58% Stats
58 (15) metoprolol
Generic
8.89% Stats
59 (5) Niaspan
Abbott Laboratories
-1.69% Stats
60 (7) Lovaza
GlaxoSmithKline
2.13% Stats
61 (5) Flovent HFA
GlaxoSmithKline
0.68% Stats
62 (8) Neupogen
Amgen Inc.
1.50% Stats
63 (11) NovoLog FlexPen
Novo Nordisk, Inc.
6.49% Stats
64 (11) ProAir HFA
Teva Pharmaceuticals
-16.08% Stats
65 (6) Reyataz
Bristol-Myers Squibb Company
-2.02% Stats
66 (1) Humalog
Eli Lilly and Company
-4.86% Stats
67 () modafinil
Generic
Stats
68 (9) Isentress
Merck & Co., Inc.
7.56% Stats
69 (3) Aranesp
Amgen Inc.
-3.66% Stats
70 (6) Janumet
Merck & Co., Inc.
2.07% Stats
71 (4) Vytorin
Merck & Co., Inc.
-1.35% Stats
72 (3) Adderall XR
Shire US Inc
-10.20% Stats
73 (6) Cialis
Eli Lilly and Company
0.32% Stats
74 (11) Velcade
Takeda Pharmaceuticals U.S.A., Inc
8.04% Stats
75 (11) Restasis
Allergan, Inc
7.28% Stats
76 (5) Pradaxa
Boehringer Ingelheim Pharmaceuticals, Inc
0.13% Stats
77 () Varivax
Merck & Co., Inc.
Stats
78 (5) fentanyl
Generic
0.10% Stats
79 (1) Aciphex
Eisai Corporation
-3.52% Stats
80 (9) Prezista
Janssen Pharmaceuticals, Inc
6.35% Stats
81 (18) budesonide
Generic
-24.99% Stats
82 (15) Orencia
Bristol-Myers Squibb Company
11.23% Stats
83 (5) acetaminophen/hydrocodone
Generic
2.66% Stats
84 (8) Prevnar 13
Wyeth
5.30% Stats
85 () Mirena
Bayer Healthcare Pharmaceuticals
Stats
86 (9) VESIcare
Astellas Pharma US
5.34% Stats
87 () Gilenya
Novartis Corporation
Stats
88 (10) Betaseron
Bayer Healthcare Pharmaceuticals
5.40% Stats
89 (2) Lunesta
Sunovion Pharmaceuticals Inc.
-4.66% Stats
90 (10) Dexilant
Takeda Pharmaceuticals U.S.A., Inc
3.24% Stats
91 Zyvox
Pfizer Inc
-3.00% Stats
92 () Evista
Eli Lilly and Company
Stats
93 (1) Benicar
Daiichi Sankyo
-1.31% Stats
94 () Renvela
Genzyme Corporation
Stats
95 (4) Erbitux
Bristol-Myers Squibb Company
-2.10% Stats
96 () Xeloda
Roche Pharmaceuticals
Stats
97 () Synthroid
Abbott Laboratories
Stats
98 () Victoza
Novo Nordisk, Inc.
Stats
99 (3) Ventolin HFA
GlaxoSmithKline
-6.88% Stats
100 (95) Seroquel
AstraZeneca Pharmaceuticals, LP
-86.23% Stats

* Units refer to the number of packages sold.

Source: IMS Health (Midas). Please review our terms of use and attribution guidelines. Copyright - All rights reserved. Unauthorized use and/or duplication of this material without express written permission is strictly prohibited.

Hide
(web2)